title: [A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].
authors.forename: Wen-juan
authors.initials: WJ
authors.lastname: Wang
authors.forename: Ai-ning
authors.initials: AN
authors.lastname: Sun
authors.forename: Hui-ying
authors.initials: HY
authors.lastname: Qiu
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D055815:Young Adult
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone; D003630:Daunorubicin